What’s in a Name? The Seizure Classification Update and What It All Means
The conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.
The Neglected Diagnosis: Mood Disorders in Patients With Epilepsy
Which came first? Epilepsy or depression? The author sheds light on a complex relationship.
Caloric Vestibular Stimulation Device Prevented Episodic Migraine
This study showed that a novel CVS device provided effective, well-tolerated adjuvant prophylactic therapy for a group of adults with episodic migraine.
Do Dairy Products Increase Risk of Parkinson Disease?
The largest study to date of a potential link between dairy intake and Parkinson disease found that risk varies depending on fat content and total intake. Details here.
Emerging Strategies for Migraine Therapy
Here’s a quick overview of what’s new—and what may be coming—in preventive treatments strategies for migraine.
Controversy Continues Regarding PPI Use and Dementia
A dementia expert addresses current controversies on proton pump inhibitors.
How Safe is Long-term Antiplatelet Rx After a Vascular Event?
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
Vertebral Artery Stenosis: Medical or Surgical Tx?
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.
Acoustic Stimulation, Sleep, and Memory
Patients underwent one night of a sham stimulation followed by pink noise stimulation delivered during slow wave activity.
Cannabis, Stroke, and Heart Failure
An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
New Parkinson Disease Treatment
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Does Metformin Increase Dementia Risk?
Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
By clicking Accept, you agree to become a member of the UBM Medica Community.